ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MWC

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
TSXV:MWC TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Medwell Capital Completes Adoption of IFRS

19/11/2011 10:45pm

PR Newswire (Canada)


(TSXV:MWC)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more  Charts.
EDMONTON, Nov. 21, 2011 /CNW/ - Medwell Capital Corp. today announced that the Company completed its adoption of International Financial Reporting Standards ("IFRS") accounting standards with the filing of amended financial statements for the three months ended March 31, 2011 and the three and six months ended June 30, 2011. The adoption of IFRS had no effect on the financial results previously reported by the Company. The adoption of IFRS by the Company was announced by the Company on October 3, 2011, and is a result of a decision from the Alberta Securities Commission to not grant exemptive relief to allow Medwell to continue reporting its financial statements using Canadian Generally Accepted Accounting Principles. About Medwell Capital Corp. Medwell Capital Corp. is a Canadian-based merchant bank that provides of capital and advisory services to the healthcare industry. For further information please visit www.medwellcapital.com. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events.  These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements.  Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Medwell Capital Corp. CONTACT: Tony Hesby Ross MarshallMedwell Capital Corp. Investor Relations780-413-7152 416-815-0700 ext. 238780-408-3040 Fax 416-815-0080 FaxE-mail: info@medwellcapital.com E-mail:rmarshall@equicomgroup.comInternet: http://www.medwellcapital.com

Copyright

1 Year Chart

1 Year  Chart

1 Month Chart

1 Month  Chart

Your Recent History

Delayed Upgrade Clock